Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

EMIF

Neuronet convenes 6th meeting of its Scientific Coordination Board

17th August 202222nd March 2021
Neuronet Scientific Coordination Board meeting 22032021

On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Alzheimer Europe sets out recommendations to improve data sharing in dementia research

21st September 202123rd February 2021
Data sharing in dementia research - the EU landscape

Luxembourg, 23 February 2021 – At an online European Parliament workshop hosted by Deirdre Clune

Neuronet Working Group on sustainability holds an online meeting, sharing sustainability plans among projects

15th October 202125th January 2021
Sustainability Working GroupPicture2

On 25 January, Neuronet hosted an online meeting of its WG on Sustainability, moderated by

Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference

10th January 202218th January 2021

In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration

Neuronet Working Group on data sharing holds an online meeting, identifying key challenges and obstacles

27th January 202122nd December 2020
Neuronet WG on data sharing

The Neuronet Working Groups (WGs) are cross-project spaces for experts to discuss common issues, priorities

Proteomics analyses of CSF samples from EMIF-MBD study identify three different subtypes of Alzheimer’s disease

28th June 202223rd November 2020
EMIF three different subtypes of Alzheimer's disease

The EMIF multimodal biomarker (EMIF-MBD) study, led by researchers based at VUmc Amsterdam and Maastricht

EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge

9th November 20209th November 2020
EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge

On November 3rd, the European Federation of Pharmaceutical Industries and Associations (EFPIA) published a blog

Showcasing IMI projects: Neuronet at #30AEC

4th November 202027th October 2020

Neuronet has been designed to boost synergy and collaboration across the projects of the Innovative

Neuronet convenes annual event on European research collaboration in Alzheimer’s disease and beyond

14th January 202225th October 2019
Neuronet annual event parallel session, José Luis Molinuevo AMYPAD; Craig Ritchie, EPAD; Mercè B oada MOPEAD; Dag Aarsland, RADAR-AD

Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together

Neuronet Scientific Coordination Board meeting brings together project leaders in The Hague

14th January 202223rd October 2019
Neuronet Scientific Coordination Board meeting The Hague Alzheimer Europe

On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second

Post navigation
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2023 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT